Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (3) , 363-369
- https://doi.org/10.1016/0959-8049(94)90257-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The biological chemistry of folate receptorsBlood, 1992
- Membrane association and shedding of the GPI‐anchored Ca‐MOv18 antigen in human ovary carcinoma cellsInternational Journal of Cancer, 1992
- Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidinEuropean Journal of Nuclear Medicine and Molecular Imaging, 1992
- Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibodyEuropean Journal of Cancer and Clinical Oncology, 1991
- Comparative Immunohistochemical Study of Four Monoclonal Antibodies Directed Against Ovarian Carcinoma-Associated AntigensInternational Journal of Gynecological Pathology, 1991
- The Ca-MOv18 molecule, a cell-surface marker of human ovarian carcinomas, is anchored to the cell membrane by phosphatidylinositolBiochemical and Biophysical Research Communications, 1990
- Folate-Binding ProteinsAnnual Review of Nutrition, 1990
- Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNABiochemistry, 1989
- Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol.Journal of Clinical Investigation, 1989
- Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificityInternational Journal of Cancer, 1987